Metraipolis › archive › dc_eaa0da94efc9
Safety and efficacy of zuranolone in Japanese adults with major depressive disorder: An open-label, repeated-treatment part of a Phase 3 clinical trial — Europe PMC PMID:41727674
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41727674
- DOI
- 10.1002/pcn5.70302
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-05T15:37:00.681Z
- SHA-256 of the archived text
62d49eade6d3a8fa8421a035e3ba5b2eb440455f1ebd0af899df67b842b2b42b- Stable URL of this page
https://metraipolis.com/documento/dc_eaa0da94efc9
How to cite
Safety and efficacy of zuranolone in Japanese adults with major depressive disorder: An open-label, repeated-treatment part of a Phase 3 clinical trial — Europe PMC PMID:41727674 — Europe PMC (en), https://europepmc.org/article/MED/41727674 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_eaa0da94efc9 (Metraipolis archive dc_eaa0da94efc9, sha256 62d49eade6d3a8fa8421a035e3ba5b2eb440455f1ebd0af899df67b842b2b42b)
BibTeX
@misc{dceaa0da94efc9,
title = {Safety and efficacy of zuranolone in Japanese adults with major depressive disorder: An open-label, repeated-treatment part of a Phase 3 clinical trial — Europe PMC PMID:41727674},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41727674},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_eaa0da94efc9; sha256 62d49eade6d3a8fa8421a035e3ba5b2eb440455f1ebd0af899df67b842b2b42b},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41727674. Agents can read the archived copy with the MCP tool read_document.